Medicxi is a life sciences investment firm established by the former Index Ventures’s life science team, a technology-oriented venture capital. The two venture firms operate under the asset-centric investment model, concentrating on a single asset of a company and cooperating with entrepreneurial scientists. Medicxi focuses on drug discovery and therapeutic development for unmet medical needs, with an investment strategy that favors biotech companies with a single drug in development. This approach goes against the common practice of keeping 'backup' candidate drugs in case the lead program goes wrong.